Article Text

Product licences and devious promotion


Platet 300 Cleartab (Nicholas) is an effervescent buffered aspirin formulation which the maker has described as “a new cardiovascular-specific presentation of aspirin “and” the only platelet aggregation inhibitor to be licensed for use following acute myocardial infarction, or in patients with unstable angina, to reduce the risk of infarction”.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.